Convergent synthesis of 2-thioether-substituted (N)-methanocarba-adenosines as purine receptor agonists. 2021

R Rama Suresh, and Russell B Poe, and Baorui Lin, and Kexin Lv, and Ryan G Campbell, and Zhan-Guo Gao, and Theodore E Liston, and Kiran S Toti, and Kenneth A Jacobson
Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bldg. 8A, Rm. B1A-19 Bethesda MD 20892-0810 USA kennethj@niddk.nih.gov +1-301-480-8422 +1-301-496-9024.

A linear route has been used to prepare (N)-methanocarba-nucleoside derivatives, which serve as purine receptor ligands having a pre-established, receptor-preferred conformation. To introduce this rigid ribose substitute, a Mitsunobu reaction of a [3.1.0]bicyclohexane 5'-trityl intermediate 3 with a nucleobase is typically followed by functional group modifications. We herein report an efficient scalable convergent synthesis for 2-substituted (N)-methanocarba-adenosines, which were demonstrated to bind to the A3 adenosine receptor. The adenine moiety was pre-functionalized with 2-thioethers and other groups before coupling to the bicyclic precursor (3) as a key step to facilitate a high yield Mitsunobu product. This new approach provided the (N)-methanocarba-adenosines in moderate to good yield, which effectively increased the overall yield compared to a linear synthesis and conserved a key intermediate 3 (a product of nine sequential steps). The generality of this convergent synthesis, which is suitable as an optimized preclinical synthetic route, was demonstrated with various 2-thioether and 2-methoxy substituents.

UI MeSH Term Description Entries

Related Publications

R Rama Suresh, and Russell B Poe, and Baorui Lin, and Kexin Lv, and Ryan G Campbell, and Zhan-Guo Gao, and Theodore E Liston, and Kiran S Toti, and Kenneth A Jacobson
April 2016, Journal of medicinal chemistry,
R Rama Suresh, and Russell B Poe, and Baorui Lin, and Kexin Lv, and Ryan G Campbell, and Zhan-Guo Gao, and Theodore E Liston, and Kiran S Toti, and Kenneth A Jacobson
February 2008, Bioorganic & medicinal chemistry,
R Rama Suresh, and Russell B Poe, and Baorui Lin, and Kexin Lv, and Ryan G Campbell, and Zhan-Guo Gao, and Theodore E Liston, and Kiran S Toti, and Kenneth A Jacobson
June 2000, Journal of medicinal chemistry,
R Rama Suresh, and Russell B Poe, and Baorui Lin, and Kexin Lv, and Ryan G Campbell, and Zhan-Guo Gao, and Theodore E Liston, and Kiran S Toti, and Kenneth A Jacobson
February 2014, Journal of medicinal chemistry,
R Rama Suresh, and Russell B Poe, and Baorui Lin, and Kexin Lv, and Ryan G Campbell, and Zhan-Guo Gao, and Theodore E Liston, and Kiran S Toti, and Kenneth A Jacobson
July 2011, European journal of medicinal chemistry,
R Rama Suresh, and Russell B Poe, and Baorui Lin, and Kexin Lv, and Ryan G Campbell, and Zhan-Guo Gao, and Theodore E Liston, and Kiran S Toti, and Kenneth A Jacobson
April 1972, Angewandte Chemie (International ed. in English),
R Rama Suresh, and Russell B Poe, and Baorui Lin, and Kexin Lv, and Ryan G Campbell, and Zhan-Guo Gao, and Theodore E Liston, and Kiran S Toti, and Kenneth A Jacobson
October 2020, ACS medicinal chemistry letters,
R Rama Suresh, and Russell B Poe, and Baorui Lin, and Kexin Lv, and Ryan G Campbell, and Zhan-Guo Gao, and Theodore E Liston, and Kiran S Toti, and Kenneth A Jacobson
September 1999, Journal of medicinal chemistry,
R Rama Suresh, and Russell B Poe, and Baorui Lin, and Kexin Lv, and Ryan G Campbell, and Zhan-Guo Gao, and Theodore E Liston, and Kiran S Toti, and Kenneth A Jacobson
December 2006, Journal of medicinal chemistry,
R Rama Suresh, and Russell B Poe, and Baorui Lin, and Kexin Lv, and Ryan G Campbell, and Zhan-Guo Gao, and Theodore E Liston, and Kiran S Toti, and Kenneth A Jacobson
March 2005, Journal of medicinal chemistry,
Copied contents to your clipboard!